|
|
 |
|
Viewing report
|
|
|
|
Global Market: Biopharmaceuticals Market Trends & Competition
Fuji-Keizai USA, Inc., June 2010, Pages: 172
Today’s pharmaceutical industry is shifting toward biopharmaceuticals at a drastic speed. In 2009, sales of biopharmaceutical drugs accounted for 13% of the total sales of pharmaceuticals. And today, biopharmaceuticals account for 25% of all pharmaceuticals in the development pipeline. We expect that biopharmaceuticals will maintain double digit growth in the years to come, and form a rapidly growing market.
Eying this dramatically expanding market, companies are expanding biopharmaceutical discovery and development, and becoming active in M&A activities including involvement in bio-ventures. As a result, competition is becoming increasingly fierce.
In this study, we describe and report on the current state and future trends of biopharmaceutical drugs in the global market, including:
1. Market Overview
2. Worldwide Biopharmaceutical Drug Market Trends, 2009-2013
3. US Biopharmaceutical Drug Market Trends
- US Sales of Biopharmaceutical Drugs by Disease Category, 2009-2013
- New Drug Market Entries by Disease Category, 2009-2013
- Manufacturers’ Share by Disease Category
4. Worldwide Innovative Biopharmaceutical Dug Development by Disease Category
- New Drug Pipelines by Disease Category
- New Players to Enter the Market by Disease Category
- Beyond the Pipeline: Hot Categories and Players’ Product Development Strategy
5. Worldwide Biopharmaceutical Drug Strategies by Major Company
- Major Alliances, M&A and IP
- Worldwide Biopharmaceutical Drug Strategies by Major Company
- Worldwide Biopharmaceutical Drug R&D by Major Company
- Patents, Business Development & Challenges for Worldwide Biopharmaceutical Drug by Major Company
6. Important Findings and Suggestions for Business Opportunities
Disease Categories:
Alzheimer’s disease, Anemia, Arthritis, Asthma, Cancer, CAPS, Diabetes, Fabry disease, Gaucher’s disease, Growth hormone deficiency, Hepatitis C, HIV, Lupus, Multiple sclerosis, Neutropenia, Osteoporosis, Parkinson’s disease, Transplant rejection, Ulcerative colitis, Vaccines, Other conditions.
Customers who bought this item also bought
Cell Therapy - Technologies, Markets and Companies
U.S. Biopharmaceutical Market - Trends, Forecast, Competition & Strategic Analysis (2009 - 2016)
Innovations in Protein Kinase Therapies: Company Pipelines, Therapeutic Applications and Market Forecasts
Biosimilars (2009 - 2014)
Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
Biopharmaceuticals - A Global Market Overview
Psoriasis - Oral and Novel Biologics to Change Future Market Dynamics
Global Bioinformatics Market Outlook
Neuroprotection - Drugs, Markets and Companies
Biosimilars - Global Strategic Business Report
|
|
|
|
